Form S-1MEF - Registration adding securities to prior Form S-1 registration [Rule 462(b)]:
SEC Accession No. 0001193125-18-216340
Filing Date
2018-07-11
Accepted
2018-07-11 21:56:12
Documents
3
Effectiveness Date
2018-07-11

Document Format Files

Seq Description Document Type Size
1 FORM S-1MEF d482239ds1mef.htm S-1MEF 41220
2 EX-23.1 d482239dex231.htm EX-23.1 1760
3 EX-23.2 d482239dex232.htm EX-23.2 2917
  Complete submission text file 0001193125-18-216340.txt   47248
Mailing Address 315 MADISON AVENUE 4TH FLOOR NEW YORK NY 10017
Business Address 315 MADISON AVENUE 4TH FLOOR NEW YORK NY 10017 (813) 864-4523
SELLAS Life Sciences Group, Inc. (Filer) CIK: 0001390478 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1MEF | Act: 33 | File No.: 333-226135 | Film No.: 18949559
SIC: 2834 Pharmaceutical Preparations